Dopamine Transporter Dat | List of Frontiers open access articles

Original Research

Published on 20 Apr 2020

Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study

in Motivation and Reward

Fabrizio Sanna
Jessica Bratzu
Maria Pina Serra
Damiana Leo
Marina Quartu
Marianna Boi
Stefano Espinoza
Raul R. Gainetdinov
Maria Rosaria Melis
Antonio Argiolas

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2020.00058

15,416 views
44 citations

Original Research

Published on 15 Jan 2019

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent

in Brain Imaging Methods

Donglang Jiang
Xiuhong Lu
Zijing Li
Nicklas Rydberg
Chuantao Zuo
Fangyu Peng
Fengchun Hua
Yihui Guan
Fang Xie

Frontiers in Neuroscience

doi 10.3389/fnins.2018.01052

6,676 views
15 citations

Mini Review

Published on 24 Aug 2023

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT

in Neurodegeneration

Maged M. Harraz

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1219441

7,286 views
11 citations

Original Research

Published on 19 Jan 2017

Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity

in Motivation and Reward

Evgeny A. Budygin
Erik B. Oleson
Yun Beom Lee
Lawrence C. Blume
Michael J. Bruno
Allyn C. Howlett
Alexis C. Thompson
Caroline E. Bass

Frontiers in Behavioral Neuroscience

doi 10.3389/fnbeh.2016.00248

6,854 views
18 citations

Original Research

Published on 04 Nov 2019

Epigenetic Regulation of the Ontogenic Expression of the Dopamine Transporter

in Epigenomics and Epigenetics

Ashley L. Green
Aseel Eid
Le Zhan
Helmut Zarbl
Grace L. Guo
Jason R. Richardson

Frontiers in Genetics

doi 10.3389/fgene.2019.01099

6,705 views
8 citations

Original Research

Published on 20 Apr 2012

Expression of Monoamine Transporters, Nitric Oxide Synthase 3, and Neurotrophin Genes in Antidepressant-Stimulated Astrocytes

in Molecular Psychiatry

Sarah Kittel-Schneider
Gunter Kenis
Julia Schek
Daniel van den Hove
Jos Prickaerts
Klaus Peter Lesch
Harry Steinbusch
Andreas Reif

Frontiers in Psychiatry

doi 10.3389/fpsyt.2012.00033

6,672 views
20 citations

Original Research

Published on 01 Feb 2019

Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons

Alexandra Krol
Violeta G. Lopez-Huerta
Taylor E. C. Corey
Karl Deisseroth
Jonathan T. Ting
Guoping Feng

Frontiers in Neural Circuits

doi 10.3389/fncir.2019.00004

9,881 views
8 citations

Review

Published on 26 May 2021

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

in Neuropharmacology

Melinda Hersey
Amanda K. Bacon
Lydia G. Bailey
Mark A. Coggiano
Amy H. Newman
Lorenzo Leggio
Gianluigi Tanda

Frontiers in Neuroscience

doi 10.3389/fnins.2021.656475

13,351 views
21 citations

Original Research

Published on 05 Jun 2020

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Yanxuan Li
Zili Zhu
Jie Chen
Minming Zhang
Yunjun Yang
Peiyu Huang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00161

6,296 views
37 citations

Original Research

Published on 25 Aug 2023

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection

in Neurodegeneration

Noor Azzizah Omar
Jaya Kumar
Seong Lin Teoh

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1236049

8,672 views
29 citations

Mini Review

Published on 27 Feb 2023

Radiomics insight into the neurodegenerative “hot” brain: A narrative review from the nuclear medicine perspective

in Radiomics and Artificial Intelligence

Gayane Aghakhanyan
Gianfranco Di Salle
Salvatore Claudio Fanni
Roberto Francischello
Dania Cioni
Mirco Cosottini
Duccio Volterrani
Emanuele Neri

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2023.1143256

3,140 views
9 citations

Original Research

Published on 09 Sep 2021

Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression

in Neuropsychology

Sara Andersson
Maria Josefsson
Lars J. Stiernman
Anna Rieckmann

Frontiers in Psychology

doi 10.3389/fpsyg.2021.729755

6,418 views
12 citations

Original Research

Published on 14 Sep 2021

Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor

in Neuropharmacology

Haibo Zhu
Wenyan Wang
Chunjie Sha
Wei Guo
Chunmei Li
Fengjuan Zhao
Hongbo Wang
Wanglin Jiang
Jingwei Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2021.741794

11,795 views
21 citations

Review

Published on 01 Mar 2022

Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder

in Neuropharmacology

Changliang Zhu
Hailiang Li
Xuerui Kong
Yezhong Wang
Tao Sun
Feng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.819470

14,205 views
25 citations

Original Research

Published on 30 Apr 2020

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder

in Neurodegeneration

Ruihua Cao
Xingui Chen
Chengjuan Xie
Panpan Hu
Kai Wang

Frontiers in Neuroscience

doi 10.3389/fnins.2020.00349

4,889 views
29 citations

Original Research

Published on 18 Feb 2022

Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila

in Psychopharmacology

Caline S. Karam
Brenna L. Williams
Irina Morozova
Qiaoping Yuan
Rony Panarsky
Yuchao Zhang
Colin A. Hodgkinson
David Goldman
Sergey Kalachikov
Jonathan A. Javitch

Frontiers in Psychiatry

doi 10.3389/fpsyt.2022.831597

4,510 views
4 citations

Articles

Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT

Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity

Epigenetic Regulation of the Ontogenic Expression of the Dopamine Transporter

Expression of Monoamine Transporters, Nitric Oxide Synthase 3, and Neurotrophin Genes in Antidepressant-Stimulated Astrocytes

Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons

Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection

Radiomics insight into the neurodegenerative “hot” brain: A narrative review from the nuclear medicine perspective

Cognitive Decline in Parkinson’s Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression

Pharmacological Characterization of Toludesvenlafaxine as a Triple Reuptake Inhibitor

Possible Mechanisms Underlying the Effects of Glucagon-Like Peptide-1 Receptor Agonist on Cocaine Use Disorder

Serial Dopamine Transporter Imaging of Nigrostriatal Function in Parkinson’s Disease With Probable REM Sleep Behavior Disorder

Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila